The risk of hypoglycemia may increase when T2DM patients with CKD are treated with multiple hypoglycemic drugs, including insulin, sulfonylureas, etc. Therefore, the dose of insulin should be reduced appropriately when combined with insulin. The gene discussed is INS; the disease is chronic kidney disease.